Please assess the completion status of the following clinical trial:

Trial Title: Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infertility due to tubal factor and/or male factor~* Age between 20 and 35 years with regular menstrual cycles of 21-35 days~* First or second cycle in the present series of ART~* BMI (body mass index) ≥ 18 ≤ 30 kg/m2~* Basal FSH (follicle stimulating hormone) \< 10 IU/L (cycle day 2-5)~* E2 (estradiol) levels \< 50pg/mL (cycle day 2)~* AMH (anti-mullerian hormone) ≥ 1.0 ng/ml~* Antral follicle ≥ 4 to ≤ 15 follicles (both ovaries)~* Presence of both ovaries and normal uterine cavity~* Informed consent~Exclusion Criteria:~* Presence of pregnancy~* Hypersensitivity to follitropin alfa~* Ovarian cysts~* History of ≥2 succeeding ART (assisted reproductive technology) cycles IVF (in vitro fertilization) and/or ICSI (Intracytoplasmic sperm injection) before the study cycle~* Previous history of severe ovarian hyperstimulation syndrome~* Presence of polycystic ovaries (PCO)~* Presence of endometriosis and hydrosalpinx~* Presence of uterine disorders~* History of poor (\< 4 oocytes) or hyper (\> 25 oocytes) responses to FSH treatment at dose 150 IU and GnRH-antagonist (gonadotropin-releasing hormone) protocol~* Premature ovarian failure~* Ectopic pregnancy (3 month before the study cycle)~* Presence of clinically significant systemic disease~* Presence of chronic cardiovascular, hepatic, renal or pulmonary disease~* Presence of endocrine disorder~* Neoplasia~* Male infertility without mobile spermatozoa in the ejaculate, that need MESA (Microsurgical epididymal sperm aspiration)/TESE (testicular sperm extraction)/TESA (testicular sperm aspiration)~* Smoking \> 10 cigarettes/day~* Narcomania, alcoholism~* Planned PGS (preimplantation genetic screeneing) /PGD (preimplantation genetic diagnosis)

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Primapur (Follitropin alfa) (Type: EXPERIMENTAL): None
- Gonal-f (Follitropin alfa) (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).